| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |